Circulating Microvesicle-Associated Inducible Nitric Oxide Synthase Is a Novel Therapeutic Target to Treat Sepsis: Current Status and Future Considerations
R. J. Webber, R. M. Sweet, D. S. Webber
This study shows anti-MV-A iNOS monoclonal antibodies can improve survival in sepsis models, with efficacy dependent on timing and dose.
bioRxiv · Nov 8, 2021Physiology